LORIGERLIMAB for Hormone-refractory prostate cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where LORIGERLIMAB was used for Hormone-refractory prostate cancer.
Most Reported Side Effects for LORIGERLIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 5 | 22.7% | 0 | 5 |
Other Drugs Used for Hormone-refractory prostate cancer
ENZALUTAMIDE (8,881)
RADIUM RA-223 DICHLORIDE (1,615)
ABIRATERONE (1,378)
DOCETAXEL (674)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579)
DAROLUTAMIDE (553)
CABAZITAXEL (524)
PREDNISONE (474)
APALUTAMIDE (365)
OLAPARIB (313)